Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sandid

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 6, 2010
[European regulation on blood and blood components]I Sandid
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 18, 2008
Use of random versus apheresis platelet concentratesG Andreu, J Vasse, I Sandid, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 17, 2013
[The blood donors' haemovigilance in France]N Ounnoughene, I Sandid, M Carlier, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 6, 2014
[Postdonation information: the French fourth hemovigilance sub-process]J-Y Py, I Sandid, S Jbilou, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2011
[Seventeen years of haemovigilance in France: assessment and outlook]M Carlier, M-P Vo Mai, L Fauveau, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 30, 2012
[Errors of red cell concentrates recipients: method of analysis using the adverse events notified to the hemovigilance network in 2009]E Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 27, 2022
Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016C Politis, J Wiersum-Osselton, C Richardson, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 6, 2010
[Patient safety and root cause analysis]Y Auroy, G Andreu, J P Aullen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 25, 2012
[Factsheets: support in the analysis of recipients' adverse reactions]A Bazin, C Trophilme, J-Y Py, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 6, 2010
[European regulation on blood and blood components]I Sandid
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 18, 2008
Use of random versus apheresis platelet concentratesG Andreu, J Vasse, I Sandid, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 17, 2013
[The blood donors' haemovigilance in France]N Ounnoughene, I Sandid, M Carlier, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 6, 2014
[Postdonation information: the French fourth hemovigilance sub-process]J-Y Py, I Sandid, S Jbilou, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2011
[Seventeen years of haemovigilance in France: assessment and outlook]M Carlier, M-P Vo Mai, L Fauveau, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 30, 2012
[Errors of red cell concentrates recipients: method of analysis using the adverse events notified to the hemovigilance network in 2009]E Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 27, 2022
Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016C Politis, J Wiersum-Osselton, C Richardson, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 6, 2010
[Patient safety and root cause analysis]Y Auroy, G Andreu, J P Aullen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 25, 2012
[Factsheets: support in the analysis of recipients' adverse reactions]A Bazin, C Trophilme, J-Y Py, et al.
Pageof 1